QCM
BMRN icon

Quantinno Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quantinno Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.95M Buy
52,147
+15,225
+41% +$888K ﹤0.01% 1395
2025
Q4 		$2.19M Buy
36,922
+16,810
+84% +$915K ﹤0.01% 1331
2025
Q3 		$1.09M Buy
20,112
+3,936
+24% +$225K ﹤0.01% 1449
2025
Q2 		$889K Buy
16,176
+3,454
+27% +$203K ﹤0.01% 1354
2025
Q1 		$899K Buy
12,722
+6,874
+118% +$462K 0.01% 1186
2024
Q4 		$384K Buy
+5,848
New +$392K ﹤0.01% 1308

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantinno Capital Management's BMRN Position: Q1 2026 in Review

Quantinno Capital Management increased its BioMarin Pharmaceuticals (BMRN) stake by 41% in Q1 2026, buying an estimated $888K and bringing the position to 52,147 shares worth $2.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1395.

Quantinno Capital Management first reported a position in BMRN in Q4 2024 and has held it in 6 quarters since. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Quantinno Capital Management held 52,147 shares of BioMarin Pharmaceuticals worth $2.95M as of Q1 2026.
  • Quantinno Capital Management bought 15,225 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $888K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1395 holding.
  • Quantinno Capital Management first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.